Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Scott Andrew Smith Insider Profile
4 Followers
Scott Andrew Smith, President and Chief Operating Officer at Celgene, holds 52.21K shares in Celgene (Ticker: CELG), holds ― shares in Titan Pharmaceuticals (Ticker: TTNP), holds 290.27K shares in BioAtla (Ticker: BCAB).
Scott Andrew Smith Celgene (CELG)President and Chief Operating Officer
Celgene (CELG)
President and Chief Operating Officer
Ranked #6,193 out of 98,624 Corporate Insiders
Profitable Transactions
5 out of 6 Profitable Transactions
Average Return
+43.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Scott Andrew Smith holds in companies
Most Profitable Insider Trade
The most profitable trade made by Scott Andrew Smith
Scott Andrew Smith's Trading History
Celgene
Feb 20, 2018
―
Uninformative Buy
221.86K
$5.65M
Titan Pharmaceuticals
―
Director
―
―
F-star Therapeutics
Jan 02, 2020
―
Uninformative Buy
―
$266.83K
BioAtla
May 01, 2024
Director
Uninformative Sell
4.93K
$943.39K
Apexigen
―
―
―
―
Viatris
Mar 05, 2024
CEO, Director
Uninformative Buy
―
$1.01M
List of latest transactions for each holding click on a transaction to see Scott Andrew Smith's performance on stock
You May Also Like
Scott Andrew Smith insider profile FAQ
What is the percentage of profitable transactions made by Scott Andrew Smith?
The percentage of profitable transactions made by Scott Andrew Smith is 83%.
What is the average return per transaction made by Scott Andrew Smith?
The average return per transaction made by Scott Andrew Smith is 43.70%.
What stocks does Scott Andrew Smith hold?
Scott Andrew Smith holds: CELG, TTNP, FSTX, BCAB, APGN, VTRS stocks.
What was Scott Andrew Smith’s latest transaction?
Scott Andrew Smith latest transaction was an Uninformative Buy of $221.86K.
What was Scott Andrew Smith's most profitable transaction?
Scott Andrew Smith’s most profitable transaction was an Informative Sell of BCAB stock on August 30, 2021. The return on the trade was 79.60%.
What is Scott Andrew Smith's role in Celgene?
Scott Andrew Smith's role in Celgene is President and Chief Operating Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.